The Dragon and the Tiger: Realties in the Control of Tuberculosis

Bhatter, Purva; Chatterjee, Anirvan; Mistry, Nerges

doi:10.1155/2012/625459

Cited by 10 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…China was one of the countries with the largest population of TB in the world. The Chinese government started to revitalize anti-TB programs in 1990s, and carried out forceful measures to achieve considerable successes in MDR-TB control [37], which could provide a good example to other developing counties. A meta-analysis con rmed that the prevalence of MDR-TB had a decreasing trend in China from 1996 to 2014 [38].…”

Section: Discussionmentioning

confidence: 99%

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Deng²,

Liang

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Antituberculosis-drug resistance is an important public health issue, and its epidemiological patterns has dramatically changed in recent decades. This study aimed to estimate the trends of multidrug-resistant tuberculosis (MDR-TB), which can be used to inform health strategies.Methods Data were collected from the Global Burden of Disease Study 2017. The estimated annual percentage changes (EAPCs) were calculated to assess the trends of MDR-TB burden at global, regional, and national level from 1990 to 2017.Results Globally, the age-standardized rate (ASR)of MDR-TB burden including incidence, prevalence, death and disability-adjusted life years (DALYs) had pronounced increasing trends from 1990 to 1999, with the EAPCs were 17.63(95% confidence interval [CI]: 10.77 to 24.92), 17.57(95%CI: 11.51 to 23.95), 21.21(95%CI:15.96 to 26.69), and 21.90(95%CI: 16.55 to 27.50), respectively. Particularly, the largest increasing trends were seen in areas and countries with low and low-middle sociodemographic index (SDI). However, the trends in incidence, prevalence, death and DALYs of MDR-TB decreased globally from 2000 to 2017, with the respective EAPCs were −1.37(95%CI: −1.62 to −1.12), −1.32(95%CI: −1.38 to −1.26), −3.30(95%CI: −3.56 to −3.04) and −3.32(95%CI: −3.59 to −3.06). Decreasing trends of MDR-TB were observed in most regions and countries, particularly that of death and DALYs in Slovenia were −18.96(95%CI: −20.82 to −17.06) and −19.35 (95%CI: −21.10 to −17.55), respectively. Whereas the pronounced increasing trends of MDR-TB occurred in Papua New Guinea, Singapore, and Australia.Conclusions The ASR of MDR-TB showed pronounced decreasing trends from 2000 to 2017. However, the MDR-TB burden remains a substantial challenge to the TB control globally, and requires effective control strategies and healthcare systems.

show abstract

Section: Discussionmentioning

confidence: 99%

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Deng²,

Liang

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…For example, a national survey in 2007 revealed a serious drug-resistant tuberculosis epidemic appeared in China, and estimated that 10% of TB patients had MDR-TB [34]. The Chinese government started to revitalize anti-TB programs in 1990s, and carried out forceful measures to achieve considerable successes in MDR-TB control [35]. A meta-analysis con rmed that the prevalence of MDR-TB had a decreasing trend in China from 1996 to 2014 [36].…”

Section: Discussionmentioning

confidence: 99%

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Deng²,

Liang

et al. 2020

Preprint

View full text Add to dashboard Cite

Background This study aimed to estimate the trends of multidrug-resistant tuberculosis (MDR-TB), which can be used to inform health strategies.Methods Data were collected from the Global Burden of Disease Study 2017. The estimated annual percentage change (EAPCs) were calculated to assess the trends of MDR-TB burden from 1990 to 2017.Results Globally, the ASR of MDR-TB burden including incidence, prevalence, death and disability-adjusted life years (DALYs) had pronounced increasing trends from 1990 to 1999, with the EAPCs were 17.63(95% confidence interval [CI]: 10.77 to 24.92), 17.57(95%CI: 11.51 to 23.95), 21.21(95%CI:15.96 to 26.69), and 21.90(95%CI: 16.55 to 27.50), respectively. Particularly, the largest increasing trends were seen in areas and countries of low and low-middle sociodemographic index (SDI). However, the trends in incidence, prevalence, death and DALYs of MDR-TB decreased globally from 2000 to 2017, with the respective EAPCs were −1.37(95%CI: −1.62 to −1.12), −1.32(95%CI: −1.38 to −1.26), −3.30(95%CI: −3.56 to −3.04) and −3.32(95%CI: −3.59 to −3.06). Decreasing trends of MDR-TB were observed in most regions and countries, particularly that of death and DALYs in Slovenia were −18.96(95%CI: −20.82 to −17.06) and −19.35 (95%CI: −21.10 to −17.55), respectively. Whereas the pronounced increasing trends of MDR-TB occurred in Papua New Guinea, Singapore, and Australia.Conclusions the ASR of incidence, prevalence, death and DALYs of MDR-TB showed decreasing trends from 2000 to 2017. However, the MDR-TB burden remains a substantial challenge to the TB control globally, and requires effective control strategies and healthcare.

show abstract

“…The general view was that the process of allocating TB-related infrastructure and training of personnel was inequitable. Both sectors require more continuous professional training ( 10 , 33 ) as it enhances quality of TB diagnosis ( 10 , 34 ). It appeared that there was lack of clarity on allocation of resources in the partnership.…”

Section: Discussionmentioning

confidence: 99%

Conforming to partnership values: a qualitative case study of public–private mix for TB control in Ghana

Amo-Adjei

2016

Global Health Action

View full text Add to dashboard Cite

BackgroundPublic–private mix (PPM) can supplement public sector initiatives, including public health. As National Tuberculosis Control Programmes around the world embrace PPM, conforming to the four key principles of partnership values of beneficence, non-maleficence, autonomy, and equity as espoused by the World Health Organization can provide a useful framework to guide successful implementation.DesignThis is a qualitative case study of PPM in tuberculosis (TB) control, which utilised a purposive sample of 30 key stakeholders involved in TB control in Ghana. Respondents comprised an equal number of respondents from both the public and private sectors. Semi-structured in-depth interviews (IDI) were conducted with respondents. Data emanating from the IDIs were analysed deductively.ResultsAlthough the respondents’ perceptions about beneficence were unanimous, their views about non-maleficence, autonomy, and equity appeared incongruous with the underlying meanings of the PPM values. Underlying the unfavourable perceptions were disruptions in funding, project implementers’ failure to follow-up on promised incentives, and private providers lost interest. This was perceived to have negatively affected the smooth implementation of PPM in the country.ConclusionsGoing forward, it is imperative that future partnerships are built around utilitarian principles and also adhere to the dictates of agreements, whether they are ‘soft’ or standard contracts.

show abstract

The Dragon and the Tiger: Realties in the Control of Tuberculosis

Cited by 10 publications

References 26 publications

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease Study

Conforming to partnership values: a qualitative case study of public–private mix for TB control in Ghana

Contact Info

Product

Resources

About